Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Macaluso steps up as Ampio CEO takes compassionate leave

This article was originally published in Scrip

Executive Summary

Don Wingerter, CEO of Ampio Pharmaceuticals, a company that discovers new uses for previously approved drugs, has been granted compassionate leave of indefinite length from all his duties to attend to the serious health problems afflicting his parents. Filling the breach is Michael Macaluso, current chair of the Ampio board of directors and lead investor in DMI BioSciences, predecessor company to Ampio.

Advertisement
Advertisement

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC015906

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel